Literature DB >> 10881110

[Concurrent leishmaniasis and human immunodeficiency virus (HIV) infection: a study of four cases].

A S Borges1, A A Machado, M S Ferreira, J F de Castro Figueiredo, G F Silva, S Cimerman, H A Bacha, M C Teixeira.   

Abstract

Few cases of concurrent leishmaniasis and HIV infection have been reported in Brazil, despite both infections being in expansion. Two cases of visceral leishmaniasis and two cases of mucocutaneous leishmaniasis are discussed. Disseminated skin and oral lesions were found in the patients with the cutaneous form of the disease. Prolonged fever, hepatosplenomegaly and pancytopenia were the main manifestations of the visceral form. The CD4 T lymphocyte count was low in all cases. Direct examination of bone marrow aspirate for leishmania and biopsy of cutaneous lesions are the techniques of choice to confirm diagnosis. Pentavalent antimonials and amphotericin B are preferred drugs for the treatment of leishmaniasis, including patients with AIDS. The authors recommend the inclusion of this parasitosis in the differential diagnosis of opportunistic diseases in patients with AIDS.

Entities:  

Mesh:

Year:  1999        PMID: 10881110

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  2 in total

Review 1.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

2.  Case Report: Coinfection by Leishmania amazonensis and HIV in a Brazilian Diffuse Cutaneous Leishmaniasis Patient.

Authors:  Gustavo Henrique Corrêa Soares; Andrea Beatrice Santos da Silva; Lucas Salomão de Sousa Ferreira; Jorim Severino Ithamar; Guilherme de Alencar Medeiros; Silma Regina Ferreira Pereira; Mayara Ingrid Sousa Lima; Conceição de Maria Pedrozo E Silva de Azevedo
Journal:  Am J Trop Med Hyg       Date:  2020-09       Impact factor: 2.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.